• Home
  • News

Zoetis Establishes Research Lab at Colorado State University to Explore Immunotherapies for Livestock

Zoetis targets livestock immunotherapies as alternatives to antibiotics

R&D incubator lab at CSU brings livestock health research, jobs to Fort Collins

Monday, July 29, 2019 10:00 am EDT

Dateline:

FORT COLLINS, COLORADO, AND PARSIPPANY, NEW JERSEY
"Forward-Looking Statements and Factors That May Affect Future Results"

FORT COLLINS, COLORADO, AND PARSIPPANY, NEW JERSEY, July 29, 2019 -- Zoetis, the world's leading animal health company, has signed an agreement with Colorado State University (CSU) to establish a research lab at CSU that will explore the livestock immune system and target new immunotherapies – paving the way for new alternatives to antibiotics in food-producing animals. The new 3,000-square-foot Zoetis Incubator Research Lab will operate at the Research Innovation Center on CSU's Foothills Campus starting in early 2020.

In this landmark R&D collaboration, Zoetis scientists will be co-located with CSU’s highly skilled scientists, core laboratories, research programs and services to seed innovations for livestock animal health. While the Zoetis Incubator Research Lab will reside within CSU’s Research Innovation Center, it will be part of the company’s global R&D organization. As a result, Zoetis may access a greater understanding of the livestock immune system, generating new candidates for further research and development. The initial focus of the Incubator Research Lab will be biotherapeutics for cattle, which could yield broader implications for pigs and poultry.

"Our agreement with Zoetis represents the beginning of an era of collaboration, cooperation and innovation between public and private research leaders, all in the interest of improving animal health," said Ray Goodrich, executive director of the Infectious Disease Research Center and a professor in the Department of Microbiology, Immunology and Pathology at CSU. 

With few alternatives today for treating life-threatening bacterial infections in animals, Zoetis supports the responsible use of antibiotic medicines in animals and in people, while ensuring that veterinarians and livestock producers have new and enhanced solutions to better predict, prevent, detect and treat disease in the animals under their care. These include new classes of antibiotics for veterinary use only and novel, non-antibiotic anti-infective treatments like those being pursued through the Zoetis Incubator Research Lab.

Going where the science is

As part of the new lab, Zoetis expects to hire up to 20 livestock research scientists, immunologists and cell biologists in Fort Collins beginning this fall.

"Zoetis is committed to continuous innovation and going where the science is. CSU is at the forefront of infectious disease innovation and animal health research in a vibrant biotech community, making it the ideal environment for our Incubator Research Lab," said Chad Ray, senior director of Global Therapeutics Research for Zoetis.  

For CSU, Goodrich added that the strategic new lab will provide multiple benefits for the campus community and the city of Fort Collins. It also bolsters CSU's land-grant mission, which includes setting the standard for public research universities in teaching, research, service and extension for the benefit of the citizens of Colorado, the United States and the world.

"The success of our efforts will have the potential to translate into products and services that may greatly improve the health and well-being of farm animals and our agricultural communities," he said.

About the CSU Research Innovation Center

The Research Innovation Center at CSU is a life-science company accelerator and is home to several startup companies with roots at the university, including SiVEC Biotechnologies LLC, which is developing antiviral applications for the rapid treatment and prevention of avian influenza. The center was originally designed to foster collaborations between private industry and CSU’s academic community. Learn more about the Research Innovation Center at https://www.research.colostate.edu/idrc/research-innovation-center/

About Zoetis

Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2018, the company generated annual revenue of $5.8 billion with approximately 10,000 employees. For more information, visit https://www.zoetisus.com/

DISCLOSURE NOTICES

Forward-Looking StatementsThis press release contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, expectations regarding products, the development of future products and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, including in the sections thereof captioned "Forward-Looking Statements and Factors That May Affect Future Results" and "Item 1A. Risk Factors," in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at  www.sec.govwww.zoetis.com, or on request from Zoetis.